מטוג'קט 10 מ"ג /מ"ל

Country: Israel

Language: Hebrew

Source: Ministry of Health

Active ingredient:

METHOTREXATE 10 MG/ML

Available from:

TZAMAL BIO-PHARMA LTD

ATC code:

L01BA01

Pharmaceutical form:

SOLUTION FOR INJECTION

Administration route:

S.C, I.V, I.M

Manufactured by:

MEDAC GESELLSCHAFT FUER KLIN.SPEZIAL.mbh

Therapeutic group:

METHOTREXATE

Therapeutic indications:

Psoriasis:because of the high risk attending its use, Methotrexate is indicated only in the symptomatic control of severe recalcitrant, disabling psoriasis which is not adequately responsive to other forms of therapy, and only when the diagnosis has been established, as by biopsy and/or after dermatological consultation. Rheumatoid Arthritis: Methotrexate can be used in the treatment of selected adults with severe rheumatoid arthritis, only when the diagnosis has been well estabished according to rheumatological standards, with inadequate response to other forms of antirheumatic therapy, including full dose NSAIDs and usually a trial of at least one or more disease-modifying antirheumatic drugs.

Authorization date:

2011-05-01